(Q38141096)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

New roles for old pathways? A circuitous relationship between reactive oxygen species and cyclo-oxygenase in hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

main subject

arterial hypertension

0 references

reactive oxygen species

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Mercedes Salaices

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

María J. Alonso

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Ana M Briones

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

1 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

111-121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

Prognostic significance of small-artery structure in hypertension.

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Small artery remodelling in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Structural abnormalities of small resistance arteries in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Role of extracellular matrix in vascular remodeling of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Matrix metalloproteinases and small artery remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Influence of hypertension on nitric oxide synthase expression and vascular effects of lipopolysaccharide in rat mesenteric arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Microsomal prostaglandin synthase-1-derived prostaglandin E2 protects against angiotensin II-induced hypertension via inhibition of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Angiotensin II differentially modulates cyclooxygenase-2, microsomal prostaglandin E2 synthase-1 and prostaglandin I2 synthase expression in adventitial fibroblasts exposed to inflammatory stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Nox proteins in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Redox regulation of Nox proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Reactive oxygen species and vascular biology: implications in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Thioredoxin in vascular biology: role in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

NAD(P)H oxidase: role in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Hsp90 regulates NADPH oxidase activity and is necessary for superoxide but not hydrogen peroxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Whole-cell and nuclear NADPH oxidases levels and distribution in human endocardial endothelial, vascular smooth muscle, and vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Regulation of Nox and Duox enzymatic activity and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular inju

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Targeting NADPH oxidases in vascular pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Cross talk between mitochondria and NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Regulation of endothelial function by mitochondrial reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Role of xanthine oxidase in hydrogen peroxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

The roles of cytochrome p450 in ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Therapeutic targeting of mitochondrial superoxide in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Hypertension increases contractile responses to hydrogen peroxide in resistance arteries through increased thromboxane A2, Ca2+, and superoxide anion levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Oxidative stress and endothelial dysfunction in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Low-dose dextromethorphan, a NADPH oxidase inhibitor, reduces blood pressure and enhances vascular protection in experimental hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Mitochondria-Targeted Antioxidant MitoQ 10 Improves Endothelial Function and Attenuates Cardiac Hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Allopurinol does not decrease blood pressure or prevent the development of hypertension in the deoxycorticosterone acetate-salt rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Long-term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Uric acid reduction rectifies prehypertension in obese adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Tetrahydrobiopterin: a novel antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Suppression of endoplasmic reticulum stress improves endothelium-dependent contractile responses in aorta of the spontaneously hypertensive rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Prostaglandin H synthase and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Signalling networks regulating cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Inhibitory effects of PPAR-gamma on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endothelin-1 increases expression of cyclooxygenase-2 and production of interlukin-8 in hunan pulmonary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endothelium-derived contracting factors mediate the Ang II-induced endothelial dysfunction in the rat aorta: preventive effect of red wine polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endothelium-mediated control of vascular tone: COX-1 and COX-2 products

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Membrane prostaglandin E synthase-1: a novel therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Prostanoid receptors in the human vascular wall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Pivotal role of protein kinase Cdelta in angiotensin II-induced endothelial cyclooxygenase-2 expression: a link to vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Prostaglandins in action indispensable roles of cyclooxygenase-1 and -2 in endothelium-dependent contractions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Role of cyclooxygenase-1-mediated prostacyclin synthesis in endothelium-dependent vasoconstrictor activity of porcine interlobular renal arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Role for thromboxane receptors in angiotensin-II-induced hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Cyclo-oxygenase-2 knockout genotype in mice is associated with blunted angiotensin II-induced oxidative stress and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Vascular COX-2 modulates blood pressure and thrombosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Cyclooxygenase inhibition and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Thromboxane receptors in smooth muscle promote hypertension, vascular remodeling, and sudden death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Differential effects of oxidative stress on hepatic endothelial and Kupffer cell eicosanoid release in response to endothelin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Selenium inhibits high glucose-induced cyclooxygenase-2 and P-selectin expression in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endoplasmic reticulum stress induced by hepatitis B virus X protein enhances cyclo-oxygenase 2 expression via activating transcription factor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endoplasmic reticulum stress induces the expression of COX-2 through activation of eIF2α, p38-MAPK and NF-κB in advanced glycation end products stimulated human chondrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2α) impairs endothelial function in renovascular hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Endothelium-dependent contractions in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Tobacco smoke regulates the expression and activity of microsomal prostaglandin E synthase-1: role of prostacyclin and NADPH-oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Peroxynitrite as regulator of vascular prostanoid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Superoxide from NADPH oxidase upregulates type 5 phosphodiesterase in human vascular smooth muscle cells: inhibition with iloprost and NONOate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Activation of thromboxane receptor modulates interleukin-1β-induced monocyte adhesion--a novel role of Nox1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

EP1c times for angiotensin: EP1 receptors facilitate angiotensin II-induced vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Reciprocal regulation of NADPH oxidases and the cyclooxygenase-2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

The effect of tempol on endothelium-dependent vasodilatation and blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

Oxygen metabolism by endothelial nitric-oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120651

21 January 2018

Identifiers

DOI

10.1042/CS20120651

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24059588%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference